News | October 07, 2011

Biosensors Acquires Top Chinese Stent Maker

October 7, 2011 — Biosensors has announced completion of its acquisition of JW Medical Systems Ltd. (JWMS), one of the top three suppliers of drug-eluting stents (DES) in China.

Biosensors previously owned 50 percent of JWMS and has now acquired the remaining half of the company from Weigao, China’s leading manufacturer of single-use medical devices. The acquisition was made through a cash and stock deal approved by the Singapore Stock Exchange (SGX) and Biosensors shareholders.

As a result of the deal, Weigao has become a key Biosensors shareholder and holds two seats on the company’s board of directors. Details of the deal can be found in the Investor Relations section of Biosensors’ website.

Coronary artery disease (CAD) is the second-biggest killer in China, accounting for 20 percent of all deaths in 2009. More than 95 percent of percutaneous coronary intervention (PCI) procedures use a DES.  Three-quarters of DES are manufactured domestically. The overall China market is currently estimated at close to half a billion U.S. dollars and is expected to continue growing rapidly over the coming years.

For more information: www.biosensors.com


Additional Content

News | Stents

Nov. 24, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...

Home November 24, 2025
Home
News | Stents

Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...

Home October 13, 2025
Home
News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
Subscribe Now